Companies with a Future performance score of at least 3, ordered by Future performance score.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
KEBNI B	SEK 1.26	6.1%	-31.9%	SEK 323.4m	SEK 1.60	3.0	82.7%	n/a	Tech
ENRAD	SEK 8.90	1.6%	-23.3%	SEK 240.4m	SEK 11.40	5.1	61.9%	n/a	Capital Goods
CAMX	SEK 548.00	1.6%	-9.1%	SEK 32.2b	SEK 771.38	48.0	35.0%	n/a	Pharmaceuticals & Biotech
HACK	SEK 76.25	0.4%	n/a	SEK 22.6b	SEK 103.49	13.1	24.8%	5.7%	Media
CLAV	SEK 4.61	6.8%	-7.8%	SEK 1.7b	n/a	486.6	73.9%	n/a	Software
BONEX	SEK 219.80	-3.9%	-20.1%	SEK 15.0b	SEK 373.83	78.2	33.8%	n/a	Pharmaceuticals & Biotech
MIPS	SEK 237.20	-0.9%	-47.0%	SEK 6.3b	SEK 492.00	48.3	42.1%	1.1%	Consumer Durables
CTT	SEK 138.00	3.4%	-34.8%	SEK 1.7b	n/a	41.6	47.1%	1.7%	Capital Goods
SKOLON	SEK 22.00	2.8%	-31.5%	SEK 573.4m	SEK 32.50	2.8	80.4%	0%	Software
EQL	SEK 25.40	4.1%	-71.5%	SEK 725.0m	SEK 50.00	59.8	67.3%	n/a	Healthcare
BIOA B	SEK 295.80	0.6%	48.3%	SEK 26.8b	SEK 301.40	123.1	53.3%	0.7%	Pharmaceuticals & Biotech
PLEJD	SEK 668.00	1.2%	n/a	SEK 7.5b	SEK 610.00	58.8	28.3%	n/a	Capital Goods
INIT	SEK 2.70	0%	-31.6%	SEK 180.7m	SEK 8.03	7.1	35.5%	n/a	Pharmaceuticals & Biotech
SBB B	SEK 3.15	4.8%	-50.1%	SEK 6.0b	SEK 3.35	3.0	96.8%	0%	Real Estate Management and Development
WAYS	SEK 41.50	1.0%	22.4%	SEK 361.3m	SEK 59.00	59.7	53.2%	0%	Tech
PCELL	SEK 23.52	-10.8%	-7.0%	SEK 1.3b	SEK 32.00	3.8	90.9%	n/a	Capital Goods
ACE	SEK 2.78	-3.6%	-35.0%	SEK 375.2m	SEK 5.60	4.5	104.9%	n/a	Pharmaceuticals & Biotech
SECT B	SEK 292.20	-3.4%	-8.0%	SEK 58.2b	SEK 336.67	99.9	23.7%	0.8%	Healthcare
GAPW B	SEK 16.80	10.2%	29.0%	SEK 566.1m	SEK 20.00	6.8	64.2%	n/a	Tech
ARFA	SEK 65.00	0.5%	n/a	SEK 616.3m	SEK 120.00	17.0	22.8%	0%	Commercial Services
MTRS	SEK 197.10	-6.4%	47.4%	SEK 35.4b	SEK 224.00	74.8	43.9%	0.8%	Capital Goods
SHOT	SEK 90.10	2.9%	12.1%	SEK 19.1b	SEK 93.86	30.1	33.8%	2.9%	Consumer Services
SYNT	SEK 27.70	0%	-13.4%	SEK 1.2b	SEK 30.00	115.3	47.4%	0%	Healthcare
KONT	SEK 2.09	-9.1%	-18.4%	SEK 73.7m	SEK 4.50	1.9	134.9%	n/a	Healthcare

High Growth Potential Companies